Estrogen effects on platelet-activating factor and plateletactivating factor acetylhydrolase activity in rat uterus during the late stages of pregnancy

Prostaglandins and Other Lipid Mediators

Volumn 57, Issue 4, 1999, Pages 219-230

  Li, Lin ^a   Yasuda, Katsuhiko ^a   Matsubara, Takashi ^a   Okada, Hidetaka ^a   Nakajima, Tatsuya ^a   Sanezumi, Mayumi ^a   Kanzaki, Hideharu ^a  

^a KANSAI MEDICAL UNIVERSITY   (Japan)

Author keywords

Estrogen; PAF; PAF Acetylhydrolase; Pregnancy; Uterus

Indexed keywords

1 ALKYL 2 ACETYLGLYCEROPHOSPHOCHOLINE ESTERASE; ALCOHOL; DIMETHYL SULFOXIDE; ESTROGEN; ETHINYLESTRADIOL; THROMBOCYTE ACTIVATING FACTOR;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVITY; FEMALE; NONHUMAN; PLASMA; PREGNANCY; PREMATURE LABOR; RABBIT; RAT; SUBCUTANEOUS DRUG ADMINISTRATION; THROMBOCYTE AGGREGATION; UTERUS; UTERUS CONTRACTION;

EID: 0033003036     PISSN: 00906980     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-6980(99)00005-2     Document Type: Article

References (38)

1. Benveniste J., Henson P.M., Cochrane C.G. Leukocyte-dependent histamine release from rabbit platelets. The role of IgE, basophils and platelet-activating factor. J Exp Med. 136:1972;1356-1377.
2. Hanahan D.J. Platelet-activating factor A biologically active phosphoglyceride . Annu Rev Biochem. 55:1986;483-509.
3. Braquet P., Touqui L., Shen T.Y., Vargaftig B.B. Perspectives in platelet-activating factor research. Pharmacol Rev. 39:1987;97-145.
4. Wallace J.L. PAF as a mediator of gastrointestinal damage. Saito K., Hanahan D.J. Platelet-activating factor and disease. 1989;153-180 International Medical Publishers, Tokyo.
5. Prescott S.M., Zimmerman G.A., Mclntyre T.M. Platelet-activating factor. J Biol Chem. 265:1990;17381-17384.
6. Kumar R., Harper M.J.K., Hanahan D.J. Occurrence of platelet-activating factor in rabbit spermatozoa. Arch Biochem Biophys. 260:1988;497-502.
7. O'Neill C. Partial characterization of the embryo-derived platelet-activating factor in mice. J Reprod Fertil. 75:1985;375-380.
8. Billah M.M., Johnston J.M. Identification of phospholipid platelet-activating factor (1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine) in human amniotic fluid and urine. Biochem Biophys Res Commun. 113:1983;51-58.
9. Yasuda K., Satouchi K., Saito K. Platelet-activating factor in normal rat uterus. Biochem Biophys Res Commun. 138:1986;1231-1236.
10. Angle M.J. Jones MA, McManus LM, Pinckard RN, Harper MJK. Platelet-activating factor in the rabbit uterus during early pregnancy. J Reprod Fertil. 83:1988;711-722.
11. Roudebush W.E., Minhas B.S., Ricker D.D., Palmer T.V., Dodson M.G., Fortunato S.J. Platelet activating factor enhances in vitro fertilization of rabbit oocytes. Am J Obstet Gynecol. 163:1990;1670-1673.
12. Ryan J.P., Spinks N.R., O'Neill C., Wales R.G. Implantation potential and fetal viability of mouse embryos cultured in media supplemented with platelet-activating factor. J Reprod Fertil. 89:1990;309-315.
13. Johnston J.M. The function of PAF in the communication between the fetal and maternal compartments during parturition. Saito K., Hanahan D.J. Platelet-activating factor and diseases. 1989;129-138 International Medical Publishers, Tokyo.
14. Tetta C., Montrucchio G., Alloati G., et al. Platelet-activating factor contracts human myometrium in vitro. Proc Soc Exp Biol Med. 183:1986;376-383.
15. Billah M.M., DiRenzo G.C., Ban C., et al. Platelet-activating factor metabolism in human amnion and the responses of this tissue to extracellular platelet-activating factor. Prostaglandins. 30:1985;841-847.
16. Matsubara T., Yasuda K., Johnston J.M., et al. Platelet activating factor (PAF) and PAF acetylhydrolase activity in rat uterus and placenta during the late stages of pregnancy. Biol Reprod. 56:1997;885-890.
17. Farr R.S., Cox C.P., Wadlow M.L., Jorgensen R. Preliminary studies of an acid-labile factor ALF in human sera that inactivates platelet-activating factor PAF. Clin Immunopathol. 15:1980;318-330.
18. Blank M.L., Lee T.-C., Fitzgerald V., Snyder F. A specific acetylhydrolase for 1-alkyl-2-acetyl-sn-glycero-3-phosphocholine (a hypotensive and platelet-activating lipid). J Biol Chem. 256:1981;175-178.
19. Blank M.L., Hall M.N., Cress E.A., Snyder F. Inactivation of 1-alkyl-2-acetyl-sn-glycero-3-phosphocholin by a plasma acetylhydrolase Higher activities in hypertensive rats . Biochem Biophys Res Commun. 113:1983;666-671.
20. Osterman G., Ruhling K., Zabel-Langhenning R., Winkler L., Schlage B., Till U. Plasma from atherosclerotic patients exerts an increased degradation of platelet-activating factor. Thromb Res. 47:1987;279-285.
21. Miwa M., Miyake T., Yamanaka T., et al. Characteristics of serum platelet-activating factor (PAF) acetylhydrolase Correlation between deficiency of serum PAF-AH on respiratory symptoms in asthmatic children . J Clin Invest. 82:1988;1983-1991.
22. Maki N., Hoffman D.R., Johnston J.M. Platelet-activating factor acetylhydrolase activity in maternal, fetal, and newborn rabbit plasma during pregnancy and lactation. Proc Natl Acad Sci USA. 85:1988;728-732.
23. Yasuda K., Johnston J.M. The hormonal regulation of platelet-activating factor-acetylhydrolase in the rat. Endocrinology. 130:1992;708-716.
24. Challis J.R.G., Olson D.M. Parturition. Knobil E., Neil J. Physiology of reproduction. 1988;2177-2216 Raven Press, New York.
25. Bligh E.G., Dyer W.J. A rapid method of total lipid extraction and purification. Can J Biochem Physiol. 37:1959;911-919.
26. Bartlett G.R. Phosphorus assay in column chromatography. J Biol Chem. 234:1959;466-468.
27. Pinckard R.N., Farr R.S., Hanahan D.J. Physicochemical and functional identity of rabbit platelet-activating factor (PAF) released in vivo during IgE anaphylaxis with PAF released in vitro from IgE sensitized basophils. J Immunol. 123:1979;1847-1857.
28. Lowry O.H., Rosenbrough N.J., Farr A.L., Randall R.J. Protein measurement with the Folin phenol reagent. J Biol Chem. 193:1951;265-275.
29. Toyoshima K, Narahara H, Furukawa M, Frenkel RA, Johnston JM. Platelet-activating factor: its role in fetal lung development and its relationship to normal and premature pregnancy. In: Caplan MS, editor. Clinics in perinatology: inflammatory mediators in perinatal health and disease. Vol. 22. New York: WB Saunders, 1995. p. 263-80.
30. Kim B.K., Ozaki H., Lee S.M., Karaki H. Increased sensitivity of rat myometrium to the contractile effect of platelet activating factor before delivery. Br J Pharmacol. 115:1995;1211-1214.
31. Wykle R.L., Malone B., Snyder F. Enzymatic synthesis of 1-alkyl-2-acetyl-sn-glycero-3-phosphocholine, a hypotensive and platelet-aggregating lipid. J Biol Chem. 255:1980;10256-10260.
32. Renooij W., Snyder F. Biosynthesis of 1-alkyl-2-acetyl-sn-glycero-3-phosphocholine (platelet activating factor and a hypotensive lipid) by cholinephosphotransferase in various rat tissues. Biochim Biophys Acta. 663:1981;545-556.
33. Stafforini D.M., Prescott S.M., McIntyre T.M. Human plasma platelet-activating factor acetylhydrolase purification and properties . J Cell Biochem. 262:1992;4223-4230.
34. Tjoelker L.W., Wilder C., Eberhardt C., et al. Anti-inflammatory properties of a platelet activating factor acetylhydrolase. Nature. 374:1995;549-553.
35. Nakayama R., Yasuda K., Okumura T., Saito K. Effect of 17β-estradiol on PAF and prostaglandin levels in oophorectomized rat uterus. Biochim Biophys Acta. 1085:1991;235-240.
36. Ihara Y., Frenkel A.R., Jhonston J.M. Hormonal regulation of platelet-activating factor acetyltransferase activity in rat tissues. Arch Biochem Biophys. 304:1993;503-507.
37. Yasuda K., Furukawa M., Johnston J.M. Effect of estrogens on plasma platelet-activating factor acetylhydrolase and the timing of parturition in the rats. Biol Reprod. 54:1996;224-229.
38. Narahara H, Nishioka Y, Johnston JM. Secretion of platelet-activating factor acetylhydrolase by human decidual macrophages. J Clin Endocrinol Metab 1993;77:1258-62. consistent throughout the paper.